Investing.com -- Evercore ISI analysts told investors in a note Monday that they are buyers of Nvidia shares ahead of this week’s earnings report, arguing that demand momentum, improving supply and ...

Aramark attributed the earnings miss primarily to approximately $25 million in additional incentive-based compensation recorded in the fourth quarter, which impacted adjusted EPS by $0.07. This ...

Investing.com -- Quantum Computing Inc. (NASDAQ:QUBT) stock surged 16% Monday after the company announced plans to debut Neurawave, a photonics-based reservoir computing system, at the upcoming ...

Investing.com -- Jazz Pharmaceuticals (NASDAQ:JAZZ) stock surged 25% after the company announced positive Phase 3 trial results for its cancer drug Ziihera in treating gastroesophageal cancer.

For the third quarter, XPeng reported revenue of 20.38 billion yuan, in line with expectations, driven by a 149.3% ...

US Dollar South African Rand, Gold Spot US Dollar, S&P 500, S&P 500. Read 's Market Analysis on Investing.com ZA.

Investing.com -- European Central Bank governing council member Gabriel Makhlouf said Monday he is "very comfortable" with the bank’s current stance on interest rates.

Investing.com -- Amazon founder Jeff Bezos will serve as co-chief executive officer of a new artificial intelligence startup called Project Prometheus, which focuses on AI for engineering and ...

Another key vulnerability for the Eurozone, in particular, revolves around high debt burdens being carried by many countries, ...

Investing.com -- Zymeworks Inc. (NASDAQ:ZYME) stock surged 57% after announcing positive topline results from its Phase 3 HERIZON-GEA-01 trial evaluating Ziihera (zanidatamab-hrii) as a first-line ...

Wall Street looks set to firm up on Monday after last week’s tech sector wobble, with Nvidia earnings due on Wednesday and ...

Investing.com -- Novo Nordisk ’s CEO Mike Doustdar said Monday that the company’s agreement with the White House to reduce prices on its popular weight-loss drugs is designed to expand access through ...